ValGenesis, Inc., the market leader in enterprise digital validation, successfully concluded its ValConnect Innovation Day series in Hyderabad, India, on November 12, following highly attended events in Princeton, New Jersey, and Frankfurt, Germany. The series is part of ValGenesis’ global initiative to drive innovation and collaboration across the industry.

These one-day in-person forums bring together industry leaders, experts, and ValGenesis customers and partners to explore advancements in digital validation and transformative technologies, including the impact of artificial intelligence (AI).

Each event, tailored to its regional audience, showcased how ValGenesis innovations help life sciences organizations accelerate time to market, enhance quality, and raise the bar for operational excellence.

Showcasing the Power of ValGenesis Smart GxP™

At the heart of the discussions was ValGenesis Smart GxP™, the company’s AI-enabled platform that unifies critical processes across the product lifecycle. Its Validation Lifecycle Suite (VLS)—featuring VAL™, the AI-powered Validation Assistant—enables organizations to accelerate commissioning, qualification, validation, and cleaning activities by generating documentation up to 80% faster, thereby optimizing execution and ensuring audit-ready compliance.

The Process Lifecycle Suite (PLS) empowers development and manufacturing teams to manage CMC data, strengthen technology transfer, and enable continued process verification (CPV) for consistent product quality. Together, VLS and PLS form an integrated ecosystem that seamlessly bridges design, development, validation, and commercial operations—giving life sciences companies a single digital platform to move faster, smarter, and more compliantly from lab to patient.

Real-World Perspectives on Digital Validation and AI in Practice

At the Hyderabad event, ValGenesis customers—including Biocon Biologics, Zydus Life Sciences Group, Dr. Reddy’s Laboratories, and Natco Pharma Limited—shared how they are leveraging ValGenesis solutions to transform their processes, strengthen compliance, and scale operations for global excellence.

Attendees also took part in interactive mentoring sessions led by ValGenesis experts, who demystified the role of AI in digital validation and explained how it can deliver immediate, real-world value within their organizations.

Turning Innovation into Impact

“Our Innovation Days showed what’s possible when the life sciences community comes together to tackle its toughest challenges,” said David Medina, Chief Marketing Officer at ValGenesis. “Through our ValGenesis Smart GxP™ vision, we demonstrated how AI-enabled digital validation is transforming the way companies operate—driving efficiency, strengthening compliance, and inspiring new ways to deliver quality.”

Beyond ValConnect

ValGenesis participates in and hosts a wide range of industry conferences, workshops, and forums. Explore opportunities to engage directly with our team, discover speaking engagements, and find events tailored to your interests by visiting the ValGenesis Events Page.

About ValGenesis Inc.

ValGenesis, Inc., is the global leader in enterprise digital validation. Serving the life sciences industry for nearly two decades, ValGenesis enables companies to digitize their commissioning, qualification, and validation processes through its AI-enabled ValGenesis Smart GxP™ Platform, which includes solutions for risk management, cleaning validation, continued process verification, and CMC development. ValGenesis helps customers worldwide reduce costs, improve compliance, and accelerate innovation. For more information visit: https://www.valgenesis.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20251118232356/en/

ValGenesis customers—including Biocon Biologics, Zydus Life Sciences Group, Dr. Reddy’s Laboratories, and Natco Pharma Limited—shared how they are leveraging ValGenesis solutions to transform their processes and scale operations for global excellence.